Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 85 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Mahtani KR, Heneghan C, Onakpoya I, Tierney S, Aronson JK, Roberts N, Hobbs R, Nunan D. Reduced salt intake for heart failure. A systematic review. JAMA Intern Med 2018:5 de noviembre. [Ref.ID 102841]
3. Cita con resumen
Aronson JK, Ferner RE. How similar are biosimilars?. BMJ 2016;353:i2721. [Ref.ID 100310]
4.Enlace a cita original
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J, for the ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705. [Ref.ID 92794]
5. Cita con resumen
Aronson JK, Hauben M, Bate A. Defining "surveillance" in drug safety. Drug Saf 2012;35:347-57. [Ref.ID 92783]
6.Enlace a cita original
Aronson JK. What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists. Br J Clin Pharmacol 2012;73:161-9. [Ref.ID 92422]
7.Enlace a cita original
de Silva HA, Pathmeswaran A, Ranasinha CD, Jayamanne S, Samarakoon SB, Hittharage A, Kalupahana R, Ratnatilaka GA, Uluwatthage W, Aronson JK, Armitage JM, Lalloo DG, de Silva HJ. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLOS Medicine 2011:mayo. [Ref.ID 90734]
8.Tiene citas relacionadas
Aronson JK. Integrating pharmacology and clinical pharmacology. Br J Clin Pharmacol 2011;71:787-90. [Ref.ID 90608]
9.Tiene citas relacionadas Cita con resumen
Aronson JK. A manifesto for clinical pharmacology from principles to practice. Br J Clin Pharmacol 2010;70:3-13. [Ref.ID 88651]
10.Tiene citas relacionadas
Aronson JK. Medication errors: definitions and classification. Br J Clin Pharmacol 2009;67:599-604. [Ref.ID 86366]
11.Tiene citas relacionadas
Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialová D, Fitzgerald RJ, Likic R, Maxwell SR, Meyboom RH, Minuz P, Onder G, Schachter M, Velo G. Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol 2009;67:592-8. [Ref.ID 86365]
12. Cita con resumen
Aronson JK, Barnett DB, Breckenridge AM, Ferner RE, Jackson P, Maxwell SR, McInnes GT, Rawlins MD, Ritter JM, Routledge P, Walley TJ, Webb DJ, Williams D, Woods KL. The UK's NHS and pharma: need for more clinical pharmacologists. Lancet 2009;373:1251-2. [Ref.ID 85618]
15. Cita con resumen
Aronson JK, Price D, Ferner RE. A strategy for regulatory action when new adverse effects of a licensed product emerge. Drug Saf 2009;32:91-8. [Ref.ID 85478]
16. Cita con resumen
17.Tiene citas relacionadas Cita con resumen
Aronson JK. Old drugs - new uses. Br J Clin Pharmacol 2007;64:563-5. [Ref.ID 81382]
19. Cita con resumen
Aronson JK, Cohen A, Ritter JM, Begg EJ, Lewis LD, Schachter M. Editors' report for 2006. Br J Clin Pharmacol 2007;64:253-4. [Ref.ID 80927]
20.
Aronson JK. Balanced prescribing. Br J Clin Pharmacol 2006;62:629-32. [Ref.ID 79887]
Seleccionar todas
 
 1 a 20 de 85 siguiente >>